Clinical trials group selling technology development subsidiary to UK firm Integumen
Venn approved to trade shares on Irish Stock Exchange’s ESM as well as on AIM
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices